Stocks-GH-Guardant Health Inc

GH Guardant Health Inc

23.52 -0.08 (-0.34%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

Overview

Prev Close 23.52
Day's Range 23.22 - 23.98
52 Week Range 15.79 - 36.94
Average Volume (3M) 2.09M
1-Year Return -15.13%
Beta1.921
Market Cap 2.89B
P/E Ratio-5.75
Revenue643.81M
EPS-4.0925
Dividend (Yield) 0 (0%)
Industry
Medical Or Nursing Services
CEO
Helmy Eltoukhy, PhD; AmirAli H. Talasaz, PhD
Employees
1,779

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Guardant Health Inc's revenues increased by 25.45% and amounted to 563.95M. Net income increased by 26.76% to -479.45M. Net assets increased by 163.68% to 158.68M and EPS increased from -6.41 to -4.28.
GH's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-300M-200M-100M0100M200M
Gross Margin
59.87%
Net Profit Margin
-92.60%
Operating Margin
-79.30%
Return On Investment
-23.97%
09/23
12/23
03/24
06/24
Total Revenue
143.03M
155.05M
168.49M
177.24M
Gross Profit
85.42M
92M
102.86M
104.48M
Operating Income
-113.04M
-197.18M
-99.19M
-100.62M
Net Income
-86.1M
-187.04M
-114.99M
-102.63M